COMPETE Act
Summary
HR8082 (COMPETE Act) is an early-stage bill referred to committee with one cosponsor and no appropriation. It proposes expanding short-term limited duration insurance to 12-month terms with renewal guarantees. Market impact is negligible at this procedural stage. The bill has no price-moving mechanism and no connection to broader energy or defense legislation.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR8082 is an early-stage bill with minimal legislative momentum (1 cosponsor, referred to committee, no hearings scheduled)
- 2.Zero dollars authorized or appropriated — this is a regulatory definitional change, not a spending bill
- 3.No market-moving mechanism exists at this procedural stage; impact on insurance stocks is neutral
- 4.If passed, ACA marketplace insurers ($CNC, $UNH) would face competitive pressure from 12-month STLDI plans, but this is speculative and distant
Market Implications
No real market data provided. The COMPETE Act is in the earliest legislative stage with zero cosponsor momentum and no appropriation. There is no near-term impact on any traded security. Managed care stocks (, , , ) have not reacted to this bill because it carries negligible passage probability in its current form. Investors should monitor whether the bill gains additional cosponsors or is scheduled for a committee hearing, which would signal elevated attention but still represent a low-probability event.
Full Analysis
-
What happened and its current status: On March 25, 2026, Rep. Grothman (R-WI) introduced HR8082, the COMPETE Act, which expands the definition of short-term limited duration insurance (STLDI) to allow contract terms up to 12 months with optional renewal guarantees. The bill was referred to the House Committee on Energy and Commerce on the same day. It is an early-stage bill with only one cosponsor (Rep. Fulcher, R-ID) and has had zero legislative action since introduction. A companion bill (S3418) has been introduced in the Senate and referred to HELP Committee, maintaining identical early-stage status.
-
The money trail: The bill authorizes zero dollars. It is a definitional amendment to the Public Health Service Act that expands a regulatory exemption from ACA market rules. No funds are authorized or appropriated. The mechanism is purely regulatory relief for STLDI issuers — they would be allowed to sell 12-month contracts with guaranteed renewal without meeting ACA essential health benefit, community rating, or guaranteed issue requirements. Actual market impact would only occur if the bill passes both chambers, is signed into law, and then insurers actually begin offering and marketing these products.
-
Structural winners and losers: If the bill were to become law, STLDI issuers (mostly smaller non-ACA insurers and broker-distributed carriers) would gain regulatory flexibility. Major ACA marketplace insurers like Centene would face competitive pressure on the individual exchange if healthier consumers shift to cheaper STLDI plans. UnitedHealth, Cigna, and Humana have diversified business models (large employer group, Medicare Advantage) that would partially insulate them from STLDI competition. The bill does not affect the employer-sponsored insurance market (which covers the majority of insured Americans), limiting its total market disruption.
-
Real market data: No real market data was provided. The bill is too early-stage and too narrow to have generated any measurable market reaction in health insurance stocks.
-
Timeline: The bill has an extremely long path to becoming law. It must pass through House Energy and Commerce Committee markups, a House floor vote, Senate HELP Committee markups, a Senate floor vote, conference committee, and be signed by the President. With only one cosponsor and no committee hearings scheduled, the probability of passage in the 119th Congress (2025-2027) is low. The companion bill in the Senate has identical early-stage status. This is likely a messaging bill rather than a active legislative priority.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
ACCESS Act
To amend the Patient Protection and Affordable Care Act to ensure that taxpayer funds for health insurance coverage are available only to authorized individuals, and for other purposes.
Insurance Fraud Accountability Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →